Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: A randomized, placebo-controlled, double-blind study (RUSSLAN)
V. S. Moiseyev, P. Põder, N. Andrejevs, M. Y. Ruda, A. P. Golikov, L. B. Lazebnik, Z. D. Kobalava, L. A. Lehtonen, T. Laine, Markku S. Nieminen, K. I. Lie
Research output: Contribution to journal › Article › peer-review
573Citations
(Scopus)
19Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: A randomized, placebo-controlled, double-blind study (RUSSLAN)'. Together they form a unique fingerprint.